StonvexLoading…
StonvexStonvexStonvexCore line items from PRCH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $109.44M | $418.89M | $306.64M | $191.56M |
Operating Income | $11.81M | $36.57M | $20.12M | $3.78M |
Net Income | $-4.71M | $-3.36M | $117.00K | $10.97M |
EPS (Diluted) | $-0.04 | $-0.03 | $0.00 | $0.10 |
Total Assets | $806.58M | $797.42M | $787.75M | $770.72M |
Total Liabilities | $780.27M | $775.04M | $777.26M | $772.90M |
Cash & Equivalents | $64.20M | $44.68M | $73.43M | $76.09M |
Free Cash Flow OCF − CapEx | $12.85M | $65.97M | $64.86M | $24.12M |
Shares Outstanding | 106.07M | 124.10M | 117.58M | 114.74M |